Risk factors for hospitalization due to lower respiratory tract infection in preterm infants on palivizumab prophylaxis

Iranian Journal of Pediatrics

Volumn 23, Issue 6, 2013, Pages 693-700

  Oncel, Mehmet Yekta ^a   Arayici, Sema ^a   Simsek, Gulsum Kadioglu ^a   Calisici, Erhan ^a   Erdeve, Omer ^b   Uras, Nurdan ^a   Oguz, Serife Suna ^a   Dilmen, Ugur ^a  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Lower respiratory tract infection; Preterm infants; Respiratory syncytial virus; Risk factors

Indexed keywords

PALIVIZUMAB;

ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREMATURITY; PROSPECTIVE STUDY; REPEATED DRUG DOSE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; RURAL AREA; SIBLING; SMOKING; SOCIAL STATUS; SUBURBAN AREA;

EID: 84890470314     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143(5 Suppl):S127-32.
2. Carbonell-Estrany X, Quero J, Bustos G, et al. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group. Pediatr Infect Dis J 2000;19(7):592-7.
3. Broughton S, Roberts A, Fox G, et al. Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 2005;60(12):1039-44.
4. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J 2003; 22(Suppl 2):S21-32.
5. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life. J Infect Dis 2004;190(10):1828-32.
6. Joffe S, Escobar GJ, Black SB, et al. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999;104(4 Pt 1):894-9.
7. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113(6):1758-64.
8. Dizdar EA, Aydemir C, Erdeve O, et al. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit. J Hosp Infect 2010; 75(4):292-4.
9. Turkish Neonatal Society. The seasonal variations of respiratory syncytial virus infections in Turkey: a 2-year epidemiological study. Turk J Pediatr 2012; 54(3):216-22.
10. Boyce TG, Mellen BG, Mitchel Jr EF, et al. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000;137(6):865-70.
11. Holman RC, Shay DK, Curns AT, et al. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J 2003;22(6):483-90.
12. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102(3 Pt 1):531-7.
13. Oncel MY, Mutlu B, Kavurt S, et al. Respiratory syncytial virus prophylaxis in preterm infants: A cost-effectiveness study from Turkey. Turk J Pediatr 2012;54(4):344-51.
14. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003;143(Suppl 5):118-26.
15. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163(7):1723-9.
16. Gregson D, Lloyd T, Buchan S, et al. Comparison of the RSV respi-strip with direct fluorescent-antigen detection for diagnosis of respiratory syncytial virus infection in pediatric patients. J Clin Microbiol 2005; 43(11):5782-3.
17. Chang AB, Chang CC, O'Grady K, et al. Lower respiratory tract infections. Pediatr Clin North Am 2009; 56(6):1303-21.
18. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375(9725):1545-55.
19. Medici MC, Arcangeletti MC, Merolla R, et al. Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy. Acta Biomed 2004;75(1):26-33.
20. Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalization for RSV infection. Arch Dis Child 2001;85(6):463-8.
21. Sommer C, Resch B, Simões EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011;5:144-54.
22. Glezen WP, Paredes A, Allison JE, et al. Risk factors for respiratory syncytial virus infection for infants from low-income families in relation to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981;98(5):708-15.
23. Jansson L, Nilson P, Olsson M. Socioeconomic enviromental factors and hospitalization for acute bronchiolitis during infancy. Acta Paediatr 2002; 91(3):335-8.
24. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004;23(9):806-14.
25. Figueras-Aloy J, Carbonell-Estrany X, Quero J; et al. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004;23(9):815-20.
26. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, et al. IRIS Study Group. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 2008;27(9):788-93.